Patents-Review.com
ClassID:

111329 ⎘

C12N2770/24163 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Flaviviridae; Flavivirus, e.g. yellow fever virus, dengue, JEV; Methods of inactivation or attenuation by chemical treatment

Recent Application in this class:
#1
20250018023
2025-01-16

Zika Virus Vaccine

 #2
20240325518
2024-10-03

METHOD FOR INACTIVATING ZIKA VIRUS AND FOR DETERMINING THE COMPLETENESS OF INACTIVATION

 #3
20240285747
2024-08-29

ZIKA VACCINES AND IMMUNOGENIC COMPOSITIONS, AND METHODS OF USING THE SAME

 #4
20240269257
2024-08-15

INORGANIC POLYATOMIC OXYANIONS FOR PROTECTING AGAINST ANTIGENIC DAMAGE DURING PATHOGEN INACTIVATION FOR VACCINE PRODUCTION

 #5
20240108712
2024-04-04

Zika virus vaccine

 #6
20230414743
2023-12-28

Zika vaccines and immunogenic compositions, and methods of using the same

 #7
20230398199
2023-12-14

Zika vaccines and immunogenic compositions, and methods of using the same

 #8
20230346910
2023-11-02

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

 #9
20230226165
2023-07-20

Zika virus vaccine

 #10
20230145065
2023-05-11

Method for inactivating zika virus and for determining the completeness of inactivation

 #11
20230122337
2023-04-20

Virus purification and formulation process

 #12
20230056142
2023-02-23

Virus purification

 #13
20220298493
2022-09-22

INACTIVATION PROCESS FOR VIRUSES

 #14
20220273786
2022-09-01

Zika virus vaccine

 #15
20220241395
2022-08-04

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

 #16
20220119777
2022-04-21

CHEMILUMINESCENCE PHOTODYNAMIC VIRUS INACTIVATION OF RED BLOOD CELLS

 #17
20210196812
2021-07-01

Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production

 #18
20210177959
2021-06-17

Method for inactivating Zika virus and for determining the completeness of inactivation

 #19
20210177958
2021-06-17

Zika vaccines and immunogenic compositions, and methods of using the same

 #20
20210093707
2021-04-01

Zika virus purification

 #21
20200384099
2020-12-10

Zika virus vaccine

 #22
20200368342
2020-11-26

Virus purification

 #23
20200360505
2020-11-19

Zika vaccines and immunogenic compositions, and methods of using the same

 #24
20200197506
2020-06-25

Virus purification

 #25
20200108094
2020-04-09

Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process

 #26
20200085939
2020-03-19

Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein

 #27
20200017555
2020-01-16

ZIKA VIRUS VACCINE

 #28
20190201520
2019-07-04

Inorganic polyatomic oxyanions for protecting against antigenic damage during pathogen inactivation for vaccine production

 #29
20190136206
2019-05-09

VIRUS PURIFICATION AND FORMULATION PROCESS

 #30
20190008945
2019-01-10

Zika virus purification

 #31
20180371027
2018-12-27

Zika virus vaccine

 #32
20180369359
2018-12-27

Virus purification

 #33
20180362937
2018-12-20

Virus purification

 #34
20180362936
2018-12-20

Zika virus purification

 #35
20170266224
2017-09-21

Cationic polyamines for treatment of viruses

 #36
20160264943
2016-09-15

Virus purification and formulation process

 #37
20160213707
2016-07-28

Cationic polyamines for treatment of viruses

 #38
20160030518
2016-02-04

COMPOSITIONS AND METHODS FOR INHIBITING VIRAL ACTIVITY

 #39
20150210986
2015-07-30

VIRUS PURIFICATION AND FORMULATION PROCESS

 #40
20140242115
2014-08-28

Inactivating pathogens with oxidizing agents for vaccine production

 #41
20130004525
2013-01-03

Inactivating pathogens with oxidizing agents for vaccine production

 #42
20110045024
2011-02-24

RNA VIRUS VACCINES AND METHODS

 #43
20110014233
2011-01-20

Psoralen-inactivated viral vaccine and method of preparation

 #44
20100129893
2010-05-27

OPTIMAL PLACEMENT OF A ROBUST SOLVENT/DETERGENT PROCESS POST VIRAL ULTRAFILTRATION OF AN IMMUNE GAMMA GLOBULIN

 #45
20090017068
2009-01-15

Vaccines against West Nile Virus

 #46
20080206279
2008-08-28

Vaccines against West Nile Virus

 #47
20070292453
2007-12-20

RNA virus vaccines and methods

 #48
20070128693
2007-06-07

Method for the inactivation and removal of dengue virus from biological samples

 #49
20070031451
2007-02-08

Inactivating pathogens with oxidizing agents for vaccine production

 #50
20060110399
2006-05-25

Optimal placement of a robust solvent/detergent process post viral ultrafiltration of an immune gamma globulin

 #51
20050186222
2005-08-25

Vaccines against West Nile Virus